1. Current Recommendations and Novel Strategies for the Management of Skin Toxicities Related to Anti-EGFR Therapies in Patients with Metastatic Colorectal Cancer

   • Maria Carmela Annunziata
   • Alfonso De Stefano
   • Ivana Romano

   Review Article 01 July 2019 Pages: 825 - 834

   

2. Bayesian Network Meta-Analysis for Assessing Adverse Effects of Anti-hepatitis B Drugs

   • Yi Shen
   • Yulong Jia
   • Pengcheng Xun

   Systematic Review 21 June 2019 Pages: 835 - 846

   

3. Proton Pump Inhibitor Therapy and Hepatic Encephalopathy Risk in Cirrhotic Patients: A Systematic Review with Meta-analysis

   • Dawei Shi
   • Ziye Zhou
   • Qinqin Cao

   Systematic Review 10 June 2019 Pages: 847 - 856

   

4. Drug–Drug Interactions in Children and Adolescents Receiving Ledipasvir/Sofosbuvir for the Treatment of Hepatitis C Virus Infection

   • Hala Mohsen Abdullatif
   • Rania Ramzi
   • Hanaa Mostafa El-Karaksy

   Original Research Article 25 June 2019 Pages: 857 - 864

5. Efficacy of Platelet-rich Plasma for Treating Androgenic Alopecia of Varying Grades

   • Qian Qu
   • Panli Shi
   • Zhiqi Hu

   Original Research Article 21 June 2019 Pages: 865 - 872

   

6. Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel Na_V1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy Volunteers

   • Michael E. Rothenberg
   • Michael Tagen
   • William Cho

   Original Research Article 06 June 2019 Pages: 873 - 887

   

7. Correction to: Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel Na_V1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy Volunteers

   • Michael E. Rothenberg
   • Michael Tagen
   • William Cho

   Correction 23 July 2019 Pages: 889 - 890

8. Determinants of Antithrombotic Treatment for Atrial Fibrillation in Octogenarians: Results of the OCTOFA Study

   • Jacques Blacher
   • Emmanuel Sorbets
   • Olivier Hoffman

   Original Research Article 10 June 2019 Pages: 891 - 898

   

9. Hypertension and Health-Related Quality of Life (HRQoL): Evidence from the US Hispanic Population

   • Elizabeth Riley
   • Jongwha Chang
   • Inho Song

   Original Research Article 12 June 2019 Pages: 899 - 908

10. Severe Exacerbation of Multiple Sclerosis Following Withdrawal of Fingolimod

    • Yara D. Fragoso
    • Tarso Adoni
    • Heloisa H. Ruocco

    Short Communication 31 May 2019 Pages: 909 - 913

    

11. Correction to: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features

    • Katherine A. Lyseng-Williamson

    Correction 17 August 2019 Pages: 915 - 916